Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI109291

Collecting Duct Sodium Reabsorption in Deoxycorticosterone-Treated Rats

John A. Haas, Theresa J. Berndt, Stephen P. Youngberg, and Franklyn G. Knox

Nephrology Research Laboratory, Department of Physiology and Biophysics, Mayo Clinic and Foundation, Rochester, Minnesota 55901

Find articles by Haas, J. in: PubMed | Google Scholar

Nephrology Research Laboratory, Department of Physiology and Biophysics, Mayo Clinic and Foundation, Rochester, Minnesota 55901

Find articles by Berndt, T. in: PubMed | Google Scholar

Nephrology Research Laboratory, Department of Physiology and Biophysics, Mayo Clinic and Foundation, Rochester, Minnesota 55901

Find articles by Youngberg, S. in: PubMed | Google Scholar

Nephrology Research Laboratory, Department of Physiology and Biophysics, Mayo Clinic and Foundation, Rochester, Minnesota 55901

Find articles by Knox, F. in: PubMed | Google Scholar

Published February 1, 1979 - More info

Published in Volume 63, Issue 2 on February 1, 1979
J Clin Invest. 1979;63(2):211–214. https://doi.org/10.1172/JCI109291.
© 1979 The American Society for Clinical Investigation
Published February 1, 1979 - Version history
View PDF
Abstract

In vitro studies of isolated, perfused, cortical collecting tubules have demonstrated that prior chronic deoxycorticosterone acetate (DOCA) treatment increases sodium reabsorption in this nephron segment, yet sodium balance in vivo is maintained. To evaluate the effect of chronic DOCA treatment on collecting duct sodium reabsorption in vivo, we compared fractional sodium delivery (FDNa%) out of the superficial late distal tubule with the fraction of sodium remaining at the base and the tip of the papillary collecting duct during extracellular fluid volume expansion in untreated, salt-treated, and DOCA-salt-treated rats. In untreated rats, FDNa% to the distal tubule was 6.5±1.0%, and to the base was 8.7±1.6% (Δ2.2±0.9%, P < 0.05). FDNa% to the tip was 4.9±1.1%, significantly less than FDNa% to the base (Δ3.7±1.1%, P < 0.01). In salt-treated rats, FDNa% to the distal tubule was 8.3±0.8%, and to the base was 10.4±1.1%. FDNa% to the tip was 5.9±0.6%, significantly less than FDNa% to the base (Δ 4.6±1.0%, P < 0.005). In DOCA-salt-treated rats, FDNa% to the distal tubule was 16.1±2.6% and to the base was 9.5±1.9% (Δ 6.6±1.7%, P < 0.005). FDNa% to the tip was 5.9±1.2%, also significantly less than FDNa% to the base (Δ 3.6±1.1%, P < 0.01). We conclude that (a) in DOCA-salt-treated rats, sodium delivery to the end of the superficial distal tubule is greater than in untreated or salt-treated rats; (b) in DOCA-salt-treated rats, sodium delivery to the end of the superficial distal tubule is greater than to the base of the papillary collecting duct, suggesting stimulation of sodium reabsorption in the cortical and(or) outer medullary collecting duct; and (c) sodium reabsorption by the papillary collecting duct is unaffected by chronic DOCA-salt treatment in the volume-expanded rat.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 211
page 211
icon of scanned page 212
page 212
icon of scanned page 213
page 213
icon of scanned page 214
page 214
Version history
  • Version 1 (February 1, 1979): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts